{"organizations": [], "uuid": "9467a2a24e3ccc579d1018972d5e003a2a192c47", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180515.html", "section_title": "Archive News &amp; Video for Tuesday, 15 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-celsius-therapeutics-launches-with/brief-celsius-therapeutics-launches-with-65-million-in-series-a-financing-idUSASC0A275", "country": "US", "domain_rank": 408, "title": "BRIEF-Celsius Therapeutics Launches With $65 Million In Series A Financing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-05-15T18:39:00.000+03:00", "replies_count": 0, "uuid": "9467a2a24e3ccc579d1018972d5e003a2a192c47"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-celsius-therapeutics-launches-with/brief-celsius-therapeutics-launches-with-65-million-in-series-a-financing-idUSASC0A275", "ord_in_thread": 0, "title": "BRIEF-Celsius Therapeutics Launches With $65 Million In Series A Financing", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "google ventures", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 15 (Reuters) - CELSIUS THERAPEUTICS:\n* CELSIUS THERAPEUTICS LAUNCHES WITH $65 MILLION IN SERIES A FINANCING TO DEVELOP PRECISION THERAPEUTICS FOR PEOPLE WITH AUTOIMMUNE DISEASES AND CANCER\n* CELSIUS THERAPEUTICS - SERIES A FINANCING LED BY THIRD ROCK VENTURES WITH PARTICIPATION FROM GV (FORMERLY GOOGLE VENTURES) AND OTHER INVESTORS Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-15T18:39:00.000+03:00", "crawled": "2018-05-16T19:08:24.000+03:00", "highlightTitle": ""}